SAO PAULO (Reuters) – The first 120,000 doses of CoronaVac, a COVID-19 vaccine developed by China’s Sinovac Biotech SVA.O that is being tested in Brazil, arrived at São Paulo’s international airport on Thursday morning, the state government said.
The doses will be stored in an undisclosed warehouse as the state awaits approval for use in Brazil by the national health regulator known as Anvisa.
Via Reuters